Anticancer results displayed that compound 58 (Fig. 39) was found to be potent one (IC50 = 1.06 μM) against MCF-7 carcinoma cells, exhibited its antagonist effect through estrogen receptor alpha. This evidence concerns the gene ESR1 and carcinoma.